Viewing Study NCT04858958


Ignite Creation Date: 2025-12-25 @ 12:17 AM
Ignite Modification Date: 2026-02-28 @ 10:51 PM
Study NCT ID: NCT04858958
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-19
First Post: 2021-04-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of FURMONERTINIB in Patients With NSCLC Having Exon 20 Insertion Mutation
Sponsor: Allist Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module